Goldman Sachs’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.3M Buy
505,900
+4,200
+0.8% +$199K ﹤0.01% 2420
2025
Q4
$22.6M Buy
501,700
+278,616
+125% +$12.9M ﹤0.01% 2266
2025
Q3
$9.97M Buy
223,084
+42,900
+24% +$2.05M ﹤0.01% 2970
2025
Q2
$8.66M Buy
180,184
+85,200
+90% +$3.71M ﹤0.01% 2886
2025
Q1
$3.81M Sell
94,984
-48,224
-34% -$2.03M ﹤0.01% 3612
2024
Q4
$6.56M Buy
143,208
+134,847
+1,613% +$6.04M ﹤0.01% 3186
2024
Q3
$392K Sell
8,361
-134,847
-94% -$6.15M ﹤0.01% 5182
2024
Q2
$6.05M Buy
+143,208
New +$6.28M ﹤0.01% 2984
2024
Q1
Sell
-47,153
Closed -$2.17M 5818
2023
Q4
$2.17M Sell
47,153
-47,153
-50% -$2.01M ﹤0.01% 3858
2023
Q3
$4.05M Hold
94,306
﹤0.01% 3174
2023
Q2
$4.5M Hold
94,306
﹤0.01% 3190
2023
Q1
$4.59M Buy
+94,306
New +$4.8M ﹤0.01% 3145
2022
Q4
Sell
-235,764
Closed -$10.3M 6217
2022
Q3
$10.3M Buy
235,764
+141,458
+150% +$6.99M ﹤0.01% 2468
2022
Q2
$4.72M Sell
94,306
-590,635
-86% -$28.8M ﹤0.01% 3191
2022
Q1
$35.6M Buy
+684,941
New +$35.4M 0.01% 1591
2020
Q4
Sell
-13,203
Closed -$732K 5662
2020
Q3
$732K Buy
+13,203
New +$685K ﹤0.01% 4278
2020
Q2
Sell
-141,458
Closed -$6.24M 5429
2020
Q1
$6.24M Sell
141,458
-122,786
-46% -$4.8M ﹤0.01% 2469
2019
Q4
$9.47M Buy
+264,244
New +$9.82M ﹤0.01% 2465
2018
Q2
Sell
-57,526
Closed -$1.97M 5940
2018
Q1
$1.97M Hold
57,526
﹤0.01% 3612
2017
Q4
$1.89M Sell
57,526
-37,723
-40% -$1.3M ﹤0.01% 3844
2017
Q3
$3.18M Sell
95,249
-99,498
-51% -$3.43M ﹤0.01% 3567
2017
Q2
$6.92M Sell
194,747
-21,137
-10% -$714K ﹤0.01% 2797
2017
Q1
$6.63M Buy
+215,884
New +$6.65M ﹤0.01% 2703

Other funds holding QGEN

Goldman Sachs's QGEN Position: Q1 2026 in Review

Goldman Sachs reduced its Qiagen (QGEN) stake by 54% in Q1 2026, selling an estimated $78.4M and leaving 1,391,327 shares worth $55.7M. The position accounts for 0.01% of the portfolio, ranked #1492.

Goldman Sachs first reported a position in QGEN in Q1 2017 and has held it in 36 quarters since. The position peaked at $181M in Q4 2022. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Goldman Sachs held 1,391,327 shares of Qiagen worth $55.7M as of Q1 2026.
  • Goldman Sachs sold 1,655,657 Qiagen shares in Q1 2026, an estimated $78.4M.
  • Qiagen made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1492 holding.
  • Goldman Sachs first reported a position in Qiagen in Q1 2017 and has held it in 36 quarters since.
  • Goldman Sachs's Qiagen position peaked at $181M in Q4 2022.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.